These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15104664)

  • 1. Sustained suppression of hepatitis C virus by high doses of interferon and ribavirin in adult hemophilic patients.
    Santagostino E; De Filippi F; Rumi MG; Rivi M; Colombo M; Mannucci PM;
    Transfusion; 2004 May; 44(5):790-4. PubMed ID: 15104664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial to determine whether continued ribavirin monotherapy in hepatitis C virus-infected patients who responded to interferon-ribavirin combination therapy will enhance sustained virologic response.
    Shiffman ML; Hofmann CM; Sterling RK; Luketic VA; Contos MJ; Sanyal AJ
    J Infect Dis; 2001 Aug; 184(4):405-9. PubMed ID: 11471097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
    Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
    Naito M; Matsui A; Inao M; Nagoshi S; Nagano M; Ito N; Egashira T; Hashimoto M; Mishiro S; Mochida S; Fujiwara K
    J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C.
    Sauleda S; Esteban JI; Altisent C; Puig L; Esteban R; Guardia J
    Thromb Haemost; 2000 Jun; 83(6):807-10. PubMed ID: 10896229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily interferon therapy for chronic hepatitis C: a report of a community practice experience.
    Srinivas D; Mani H; Crumpler C; Van Thiel DH
    Hepatogastroenterology; 2002; 49(46):1053-7. PubMed ID: 12143200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of chronic hepatitis C treatment in hemophilic patients.
    Husa P; Roznovsky L; Smejkal P; Husova L; Penka M; Dite P
    Hepatogastroenterology; 2005; 52(65):1541-4. PubMed ID: 16201114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful treatment of chronic hepatitis C in hemophiliacs based on historical development of therapeutic protocols].
    Husa P; Smejkal P; Husová L; Chalupa P; Penka M
    Vnitr Lek; 2004 Jan; 50(1):30-5. PubMed ID: 15015227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained response to interferon-ribavirin combination therapy predicted by a model of hepatitis C virus dynamics using both HCV RNA and alanine aminotransferase.
    Colombatto P; Civitano L; Oliveri F; Coco B; Ciccorossi P; Flichman D; Campa M; Bonino F; Brunetto MR
    Antivir Ther; 2003 Dec; 8(6):519-30. PubMed ID: 14760885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interferon therapy of chronic viral hepatitis in Hungary: 5-year experience. A multicenter study].
    Pár A; Telegdy L; Gógl A; Müller E
    Orv Hetil; 1999 May; 140(22):1227-33. PubMed ID: 10377733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy.
    Mancuso ME; Rumi MG; Aghemo A; Santagostino E; Puoti M; Coppola A; Colombo M; Mannucci PM
    J Thromb Haemost; 2009 Dec; 7(12):1997-2005. PubMed ID: 19799716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Future outlook for treatment of chronic hepatitis C: IFN + ribavirin combination therapy].
    Iino S
    Rinsho Byori; 2001 Aug; 49(8):747-54. PubMed ID: 11573281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapy.
    Santagostino E; Rumi MG; Rivi M; Colombo M; Mannucci PM;
    Blood; 2002 Feb; 99(3):1089-91. PubMed ID: 11807019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum B12 levels predict response to treatment with interferon and ribavirin in patients with chronic HCV infection.
    Rosenberg P; Hagen K
    J Viral Hepat; 2011 Feb; 18(2):129-34. PubMed ID: 20196801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of low-dose interferon therapy for treating chronic hepatitis C patients who cannot tolerate standard treatment].
    Cao ZH; Liu YL; Zheng YH; Ji SD; Wang JL; Liao JH; Zhang CY; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):20-4. PubMed ID: 22464701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.